Is Medtronic PLC Stock a Good Investment?

Medtronic PLC Investment Advice

  MDT
To provide specific investment advice or recommendations on Medtronic PLC stock, we recommend investors consider the following general factors when evaluating Medtronic PLC. This will help you to make an informed decision on whether to include Medtronic PLC in one of your diversified portfolios:
  • Examine Medtronic PLC's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Medtronic PLC's leadership team and their track record. Good management can help Medtronic PLC navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Medtronic PLC's business and its evolving consumer preferences.
  • Compare Medtronic PLC's performance and market position to its competitors. Analyze how Medtronic PLC is positioned in terms of product offerings, innovation, and market share.
  • Check if Medtronic PLC pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Medtronic PLC's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Medtronic PLC stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Medtronic PLC is a good investment.
 
Sell
 
Buy
Strong Hold
Macroaxis provides trade recommendations on Medtronic PLC to complement and cross-verify current analyst consensus on Medtronic PLC. Our advice engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Medtronic PLC is not overpriced, please verify all Medtronic PLC fundamentals, including its shares owned by institutions, cash per share, number of employees, as well as the relationship between the revenue and cash flow from operations . Given that Medtronic PLC has a price to earning of 20.44 X, we recommend you to check Medtronic PLC market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

Fairly ValuedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

HealthyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine Medtronic PLC Stock

Researching Medtronic PLC's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 85.0% of the company shares are owned by institutional investors. The book value of Medtronic PLC was now reported as 38.29. The company has Price/Earnings To Growth (PEG) ratio of 1.59. Medtronic PLC last dividend was issued on the 27th of September 2024. The entity had 2:1 split on the 27th of September 1999.
To determine if Medtronic PLC is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Medtronic PLC's research are outlined below:
Medtronic PLC generated a negative expected return over the last 90 days
Over 85.0% of the company shares are owned by institutional investors
On 11th of October 2024 Medtronic PLC paid $ 0.7 per share dividend to its current shareholders
Latest headline from investing.com: Disposition of 1540 shares by Gary Corona of Medtronic PLC at 80.0 subject to Rule 16b-3

Medtronic PLC Quarterly Liabilities And Stockholders Equity

90.04 Billion

Medtronic PLC uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Medtronic PLC. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Medtronic PLC's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
20th of February 2024
Upcoming Quarterly Report
View
23rd of May 2024
Next Financial Report
View
31st of January 2024
Next Fiscal Quarter End
View
23rd of May 2024
Next Fiscal Year End
View
31st of October 2023
Last Quarter Report
View
30th of April 2023
Last Financial Announcement
View
Earnings surprises can significantly impact Medtronic PLC's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Medtronic PLC's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-05-21
2020-04-300.680.58-0.114 
2021-02-23
2021-01-311.151.290.1412 
2020-11-24
2020-10-310.81.020.2227 
2020-08-25
2020-07-310.180.620.44244 

Know Medtronic PLC's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Medtronic PLC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medtronic PLC backward and forwards among themselves. Medtronic PLC's institutional investor refers to the entity that pools money to purchase Medtronic PLC's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Deutsche Bank Ag2024-06-30
16.7 M
Franklin Resources Inc2024-09-30
16.6 M
Norges Bank2024-06-30
15.6 M
Legal & General Group Plc2024-06-30
11.6 M
Royal Bank Of Canada2024-06-30
11.4 M
Northern Trust Corp2024-09-30
11.4 M
Ameriprise Financial Inc2024-06-30
10.9 M
Amvescap Plc.2024-06-30
10.8 M
Alliancebernstein L.p.2024-06-30
10.7 M
Vanguard Group Inc2024-09-30
123.4 M
Blackrock Inc2024-06-30
111.9 M
Note, although Medtronic PLC's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Medtronic PLC's market capitalization trends

The company currently falls under 'Mega-Cap' category with a total capitalization of 109.89 B.

Market Cap

166.39 Billion

Medtronic PLC's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets 0.10  0.11 
Return On Capital Employed 0.06  0.05 
Return On Assets 0.04  0.04 
Return On Equity 0.07  0.07 
The company has Net Profit Margin of 0.12 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.18 %, which entails that for every 100 dollars of revenue, it generated $0.18 of operating income.
Determining Medtronic PLC's profitability involves analyzing its financial statements and using various financial metrics to determine if Medtronic PLC is a good buy. For example, gross profit margin measures Medtronic PLC's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Medtronic PLC's profitability and make more informed investment decisions.

Medtronic PLC's Earnings Breakdown by Geography

Please note, the imprecision that can be found in Medtronic PLC's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medtronic PLC. Check Medtronic PLC's Beneish M Score to see the likelihood of Medtronic PLC's management manipulating its earnings.

Evaluate Medtronic PLC's management efficiency

Medtronic PLC has Return on Asset of 0.0442 % which means that on every $100 spent on assets, it made $0.0442 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0795 %, implying that it generated $0.0795 on every 100 dollars invested. Medtronic PLC's management efficiency ratios could be used to measure how well Medtronic PLC manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.11 in 2024, whereas Return On Capital Employed is likely to drop 0.05 in 2024. Total Current Liabilities is likely to gain to about 11.3 B in 2024. Liabilities And Stockholders Equity is likely to gain to about 94.5 B in 2024
Last ReportedProjected for Next Year
Book Value Per Share 37.98  38.37 
Tangible Book Value Per Share(2.86)(6.02)
Enterprise Value Over EBITDA 15.93  24.28 
Price Book Value Ratio 2.11  3.42 
Enterprise Value Multiple 15.93  24.28 
Price Fair Value 2.11  3.42 
Enterprise Value179 B187.9 B
Management at Medtronic PLC focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Dividend Yield
0.032
Forward Dividend Yield
0.032
Forward Dividend Rate
2.8
Beta
0.853

Basic technical analysis of Medtronic Stock

As of the 28th of November, Medtronic PLC secures the Standard Deviation of 1.05, mean deviation of 0.7737, and Risk Adjusted Performance of (0.03). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medtronic PLC, as well as the relationship between them.

Medtronic PLC's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Medtronic PLC insiders, such as employees or executives, is commonly permitted as long as it does not rely on Medtronic PLC's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Medtronic PLC insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Medtronic PLC's Outstanding Corporate Bonds

Medtronic PLC issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Medtronic PLC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Medtronic bonds can be classified according to their maturity, which is the date when Medtronic PLC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand Medtronic PLC's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Medtronic PLC's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Medtronic PLC's intraday indicators

Medtronic PLC intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Medtronic PLC stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Medtronic PLC Corporate Filings

10Q
26th of November 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
8K
19th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
24th of October 2024
Other Reports
ViewVerify
5th of September 2024
Other Reports
ViewVerify
Medtronic PLC time-series forecasting models is one of many Medtronic PLC's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Medtronic PLC's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Medtronic Stock media impact

Far too much social signal, news, headlines, and media speculation about Medtronic PLC that are available to investors today. That information is available publicly through Medtronic media outlets and privately through word of mouth or via Medtronic internal channels. However, regardless of the origin, that massive amount of Medtronic data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Medtronic PLC news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Medtronic PLC relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Medtronic PLC's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Medtronic PLC alpha.

Medtronic PLC Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Medtronic PLC can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Medtronic PLC Historical Investor Sentiment

Investor biases related to Medtronic PLC's public news can be used to forecast risks associated with an investment in Medtronic. The trend in average sentiment can be used to explain how an investor holding Medtronic can time the market purely based on public headlines and social activities around Medtronic PLC. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Medtronic PLC's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Medtronic PLC and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Medtronic PLC news discussions. The higher the estimate score, the more favorable the investor's outlook on Medtronic PLC.

Medtronic PLC Corporate Directors

Scott DonnellyLead Independent DirectorProfile
Richard AndersonLead Independent DirectorProfile
Elizabeth NabelIndependent DirectorProfile
James LenehanIndependent DirectorProfile

Additional Tools for Medtronic Stock Analysis

When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.